Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR
- 23 June 2004
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 22 (19), 2457-2469
- https://doi.org/10.1016/j.vaccine.2003.12.033
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Can needle-free administration of vaccines become the norm in global immunization?Nature Medicine, 2003
- Intussusception among Infants Given an Oral Rotavirus VaccineThe New England Journal of Medicine, 2001
- Epithelial M Cells: Differentiation and FunctionAnnual Review of Cell and Developmental Biology, 2000
- Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in miceVaccine, 1999
- Epithelial M Cells: Gateways for Mucosal Infection and ImmunizationCell, 1996
- Compartmentalization within the Common Mucosal Immune SystemAdvances in experimental medicine and biology, 1995
- Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruitsThe Lancet, 1994
- Live oral vaccines against cholera: An updateVaccine, 1993
- Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trialThe Lancet, 1990
- History of Sabin attenuated poliovirus oral live vaccine strainsJournal of Biological Standardization, 1973